RHB Retail Research says Duopharma Biotech Berhad attempted to cross above the MYR1.67 resistance in the latest session.
In a trading note, the research house says an upside breach of this level, which coincides with the rising 21-day SMA line, could see the stock testing the MYR1.75 resistance, followed by MYR1.80.
“A stop-loss can be placed below MYR1.65,” it says.
